INSIGHTS ON DRUG DEVELOPMENT

• Bioprocess Optimization: Leveraging Functional DOE With Time-Based Insights

  Explore the key differences between traditional DOE and Functional DOE as Seongjin Kim demonstrates how the latter enhances bioprocess optimization through a fed-batch cell culture example.

• Take Action On PFAS To Protect Your Critical Processes

  PFAS restrictions are tightening, but a full ban could disrupt critical industries lacking alternatives, such as pharmaceutical manufacturing. Learn where PFAS use remains indispensable.

• Formulating Better ASDs And mAbs: Advances In Applied Nanotechnology

  Learn about new data on nanotechnology formulations for multiple dose forms and routes of delivery, including oral, long-acting injectables, inhalation, and ophthalmic.

• Advancements In GLP-1 Analog Formulation: Overcoming Challenges

  Oral GLP-1 formulations represent a groundbreaking advance in obesity treatment to offer improved patient comfort and adherence while expanding the therapeutic market.

• Preclinical Evaluation Of Antifibrotics In COVID-Induced Fibrosis Model

  6/10/2025

  Advancing the development of effective antifibrotic therapies requires urgent investment in clinically relevant, IND-enabling preclinical models to address the growing burden of fibrotic diseases.

• Futurizing Healthcare By Localizing The Life Sciences

  12/12/2024

  Mustapha Bittaye's journey highlights the importance of international funding in fostering local scientific talent and biopharma resilience, empowering research and manufacturing in developing countries.

• Nitrosamine Impurities: Are Your Products Compliant?

  11/6/2023

  Potential strategies for vulnerable drug products include shelf-life reduction, investigating nitrite contribution from excipient suppliers, examining formulation processes, and introducing additives.

• Experimental CCI — Induced Neuropathic Pain Model

  6/18/2025

  Advance neuropathic pain research and therapeutic development with the Chronic Constriction Injury (CCI)-induced neuropathic pain model to uncover mechanisms and evaluate promising candidates.

• What Are ATMPs And Why Do They Matter?

  3/28/2025

  Delves into the evolution of Advanced Therapy Medicinal Products (ATMPs), exploring their complex development, revolutionary potential in treating diseases, and the intricacies of cell and gene therapies.